← Back to Search

Other

CBD oil for Healthy Adults

Phase 1
Recruiting
Research Sponsored by Canopy Growth Corporation
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up day 34
Awards & highlights

Study Summary

This trial is testing if a new drug is safe to take with alcohol.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~day 34
This trial's timeline: 3 weeks for screening, Varies for treatment, and day 34 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Adverse Events/Serious Adverse Events
Change from baseline in Alanine aminotransferase (ALT)
Change from baseline in blood pressure
Secondary outcome measures
Peak Blood Alcohol Level (BAL)

Side effects data

From 2022 Phase 4 trial • 4 Patients • NCT05209867
25%
Neck pain
100%
80%
60%
40%
20%
0%
Study treatment Arm
CBD Intervention

Trial Design

6Treatment groups
Experimental Treatment
Group I: Randomization order 6Experimental Treatment2 Interventions
Participants receive 100 mg CBD at visit 1, placebo at visit 2, and 50 mg CBD at visit 3 followed by a 4-week period of at home use of 100 mg CBD daily.
Group II: Randomization order 5Experimental Treatment2 Interventions
Participants receive 100 mg CBD at visit 1, 50 mg CBD at visit 2, and placebo at visit 3 followed by a 4-week period of at home use of 100 mg CBD daily.
Group III: Randomization order 4Experimental Treatment2 Interventions
Participants receive 50 mg CBD at visit 1, 100 mg CBD at visit 2, and placebo at visit 3 followed by a 4-week period of at home use of 100 mg CBD daily.
Group IV: Randomization order 3Experimental Treatment2 Interventions
Participants receive 50 mg CBD at visit 1, placebo at visit 2, and 100 mg CBD at visit 3 followed by a 4-week period of at home use of 100 mg CBD daily.
Group V: Randomization order 2Experimental Treatment2 Interventions
Participants receive placebo at visit 1, 100 mg CBD at visit 2, and 50 mg CBD at visit 3 followed by a 4-week period of at home use of 100 mg CBD daily.
Group VI: Randomization order 1Experimental Treatment2 Interventions
Participants receive placebo at visit 1, 50 mg CBD at visit 2, and 100 mg CBD at visit 3 followed by a 4-week period of at home use of 100 mg CBD daily.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
CBD oil
2022
Completed Phase 4
~10
Placebo
1995
Completed Phase 3
~2670

Find a Location

Logistics

Participation is compensated

You will be compensated for participating in this trial.

Who is running the clinical trial?

Canopy Growth CorporationLead Sponsor
13 Previous Clinical Trials
1,124 Total Patients Enrolled
2 Trials studying Healthy Adults
322 Patients Enrolled for Healthy Adults
Auburn UniversityLead Sponsor
71 Previous Clinical Trials
14,330 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many participants are currently engaged in this clinical experimentation?

"Correct. According to clinicaltrials.gov, this research program is currently recruiting subjects and was first shared on May 9th 2022. The most recent update occurred on August 9th 2022 and the study seeks 30 people from one site."

Answered by AI

What adverse effects could be caused by consuming CBD oil?

"Due to its status as a Phase 1 trial, the safety level of CBD oil was rated at 1 on our team's scale. This is because there are limited data sets that demonstrate both efficacy and security."

Answered by AI

Does the research team permit seniors aged 75 and over to participate?

"The conditions for enrolment in this trial stipulate that patient must be over the age of 21 and under 65 years old."

Answered by AI

What type of participant is best suited for this trial?

"Eligible participants must be adults between 21 and 65 years old with no pre-existing health conditions. A total of 30 people will be admitted to the trial."

Answered by AI

Does this research currently accept new participants?

"The data posted on clinicaltrials.gov indicates that the recruitment process for this trial is underway, having begun on May 9th 2022 and receiving its most recent update on August 9th of the same year."

Answered by AI

Who else is applying?

What state do they live in?
Georgia
How old are they?
18 - 65
What site did they apply to?
Auburn University
What portion of applicants met pre-screening criteria?
Met criteria
~11 spots leftby Mar 2025